<i id='970D5C7162'><strike id='970D5C7162'><tt id='970D5C7162'><pre id='970D5C7162'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
Trump demands the U.S. pay no more for drugs than other countries … again 
Why an extreme heat and wildfire smoke combination can be so dangerous 
23andMe had bad news about my health. I wish a person had delivered it 
For one rare type of lung cancer, Pfizer pill reduces progression by 81% 
The Supreme Court will review a ruling striking down a domestic violence federal gun ban 
ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers 
At least 13 dead in Texas as scorching temps continue 
At ASCO, AstraZeneca reports strong data for breast cancer drug 
Affirmative action in medical school literally saved lives 
Letters to First Opinion on caregivers, digital health, and more 
New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum 
ASCO: AstraZeneca's hat trick, and palliative care's spotlight 
Psychedelics group wrestles with new pharma identity 
Artificial intelligence advances fuel industry trying to preserve loved ones after death 
Medicare details structure of new drug price negotiation program 
